Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Arteriosclerosis, Thrombosis, and Vascular Biology. 1982;2:68-73

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehnholm, C.
Right arrow Articles by Cantell, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehnholm, C.
Right arrow Articles by Cantell, K.

Arteriosclerosis, Vol 2, 68-73, Copyright © 1982 by American Heart Association

ARTICLES

Effect of interferon on plasma lipoproteins and on the activity of postheparin plasma lipases

C Ehnholm, K Aho, JK Huttunen, E Kostiainen, K Mattila, J Pakkarainen and K Cantell

The effect of interferon administration on the concentration of plasma lipoproteins and on the activity of postheparin plasma lipoprotein lipase and hepatic lipase was studied in six healthy men. Daily injection of human leukocyte interferon for 1 week lowered the plasma level of total cholesterol, very low density lipoprotein + low density lipoprotein cholesterol, high density lipoprotein cholesterol, and apolipoprotein A-1 in all subjects. Simultaneously, the activity of postheparin plasma hepatic lipase and lipoprotein lipase decreased by 20% to 50%. These observations may be of importance in the interpretation of lipoprotein changes seen in acute and chronic infections and should be borne in mind when prolonged treatment with interferon is considered.


This article has been cited by other articles:


Home page
 LupusHome page
M McMahon, J Grossman, W Chen, and B H Hahn
Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus
Lupus, November 1, 2006; 15(11_suppl): 59 - 69.
[Abstract] [PDF]

Home page
 Endocr. Rev.Home page
S.-C. J. Yeung, A. C. Chiu, R. Vassilopoulou-Sellin, and R. F. Gagel
The Endocrine Effects of Nonhormonal Antineoplastic Therapy
Endocr. Rev., April 1, 1998; 19(2): 144 - 172.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. K. Kwong, D. N. Ridinger, M. Bandhauer, J. H. Ward, W. E. Samlowski, P.-H. Iverius, H. Pritchard, and D. E. Wilson
Acute Dyslipoproteinemia Induced by Interleukin-2: Lecithin:Cholesteryl Acyltransferase, Lipoprotein Lipase, and Hepatic Lipase Deficiencies
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1572 - 1581.
[Abstract] [Full Text] [PDF]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1982 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.